Nicolás Montes-Bravo

Nicolás Montes-Bravo

Auto-generated profile, based on publicly available information

Nicolás Montes-Bravo

ANID – Millennium Science Initiative Program - Millennium Nucleus in the Biology of the Intestinal Microbiota, Santiago, Chile

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Anaerobe
Verified
Journal Article
Open access
EBEugénie Bassères
Eugénie Bassères
BEBradley T. Endres
Bradley T. Endres
NMNicolás Montes-Bravo
Nicolás Montes-Bravo
NPNicolás Pérez-Soto
Nicolás Pérez-Soto
TRTasnuva Rashid
Tasnuva Rashid
KGKevin W Garey
Kevin W Garey
Fidaxomicin has novel pharmacologic effects on C. difficile spore formation including outgrowth inhibition and persistent spore attachment. However, the mechanism of fidaxomicin attachment on spores has not undergone rigorous microscopic studies. Fidaxomicin attachment to C. difficile spores of three distinct ribotypes and C. difficile mutant spores with inactivation of exosporium or spore-coat protein-coding genes were visualized using confocal microscopy with a fidaxomicin-bodipy compound (green fluorescence). The pharmacologic effect of the fidaxomicin-bodipy compound was determined. Confocal microscopy experiments included direct effect on C. difficile wild-type and mutant spores, effect of exosporium removal, and direct attachment to a comparator spore forming organism, Bacillus subtilis. The fidaxomicin-bodipy compound MIC was 1 mg/L compared to 0.06 mg/L for unlabeled fidaxomicin, a 16-fold increase. Using confocal microscopy, the intracellular localization of fidaxomicin into vegetative C. difficile cells was observed consistent with its RNA polymerase mechanism of action and inhibited spore outgrowth. The fidaxomicin-bodipy compound was visualized outside of the core of C. difficile spores with no co-localization with the membrane staining dye FM4-64. Exosporium removal reduced fidaxomicin-bodipy association with C. difficile spores. Reduced fidaxomicin-bodipy was observed in C. difficile mutant spores for the spore surface proteins CdeC and CotE. This study visualized a direct attachment of fidaxomicin to C. difficile spores that was diminished with mutants of specific exosporium and spore coat proteins. These data provide advanced insight regarding the anti-spore properties of fidaxomicin.

25 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MPMarjorie Pizarro-Guajardo
Marjorie Pizarro-Guajardo
CBChristian Brito-Silva
Christian Brito-Silva
PCPablo Castro-Córdova
Pablo Castro-Córdova
NMNicolás Montes-Bravo
Nicolás Montes-Bravo
ECEduardo Alberto Callegari
Eduardo Alberto Callegari
Daniel ParedesDaniel Paredes
Daniel Paredes
Clostridioides difficile infection (CDI) is characterized by toxin-mediated epithelial injury, intestinal inflammation, and a high frequency of disease recurrence. Although complement components are produced locally within the gastrointestinal tract, their contribution to C. difficile pathogenesis remains poorly understood. Here, we investigated the interaction of the complement proteins C1q and C3 with C. difficile spores and their contribution to spore–host interactions and disease outcome. We found that C1q and C3 are accessible within the healthy ileal mucosa and that TcdB intoxication differentially remodels their spatial availability, decreasing accessible C1q while increasing accessible C3 at higher toxin concentrations. C. difficile spores associated with both complement components in vivo and directly interacted with purified human C1q and C3 in vitro, with immunogold electron microscopy localizing these interactions to the outer exosporium. Although the collagen-like BclA proteins modulated complement binding under some conditions, they were not required for C1q or C3 association. Far-Western analysis coupled to mass spectrometry identified the exosporium proteins CotE and CdeM as candidate complement-interacting proteins, and purified CdeM inclusion bodies directly associated with both C1q and C3. Exposure of spores to human serum promoted their interaction with intestinal epithelial cells, whereas depletion of either C1q or C3 markedly reduced spore internalization and reconstitution with the corresponding purified protein partially restored entry. C3-derived species, including C3dg, were selectively associated with spores but not vegetative cells, without reducing spore viability. Finally, C1q deficiency did not alter the initial onset of CDI but accelerated recovery and markedly attenuated recurrent disease following vancomycin treatment. Together, these findings identify intestinal complement as a previously unrecognized component of the C. difficile spore–host interface and reveal C1q and C3 as modulators of spore epithelial entry, persistence, and recurrent disease. Author summary: Clostridioides difficile is a major cause of antibiotic-associated diarrhea, and recurrent infections remain difficult to prevent. Disease recurrence depends in part on highly resistant spores that persist in the intestine and can interact with the intestinal lining. Here, we show that two components of the complement immune system, C1q and C3, are present and accessible in the intestinal mucosa and can associate directly with C. difficile spores. We identified the spore surface protein CdeM as one molecular component capable of interacting with both C1q and C3. These complement proteins also enhanced the ability of spores to enter intestinal epithelial cells, suggesting that a host defense pathway can be exploited by the pathogen to promote interactions with the intestinal barrier. C3 was deposited and processed on spores but did not reduce their viability. Importantly, mice lacking C1q recovered more rapidly from infection and developed markedly less recurrent disease after antibiotic treatment. These findings reveal an unexpected role for intestinal complement in C. difficile pathogenesis and suggest that complement–spore interactions may contribute to persistence and recurrence.